Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia

Summary

The study intervention involved in this study is the addition of a dose of volasertib as a part of the initial chemotherapy regimen for AML. The trial will involve a combination of the following drugs: * Volasertib (the study drug) * Idarubicin * Cytarabine

Timeline

Start

2016-09

Primary completion

2017-02

Completion

2017-02

Outcome

Outcome not reported

Stopped (Business): “Funding Withdrawn”

Drugs

Indications